Implementation of digital health technology in clinical trials: the 6R framework
Nat Med
.
2023 Nov;29(11):2693-2697.
doi: 10.1038/s41591-023-02489-z.
Authors
Cristina Ortega Durán
1
,
Matthew Bonam
2
,
Elisabeth Björk
3
,
Rod Hughes
4
,
Serban Ghiorghiu
5
,
Cristian Massacesi
6
,
Alicyn Campbell
7
,
Emmette Hutchison
8
,
Menelas N Pangalos
9
,
Susan Galbraith
10
Affiliations
1
Digital Health Research and Development, AstraZeneca PLC, Cambridge, UK. Cristina.Duran@astrazeneca.com.
2
Digital Health Research and Development, AstraZeneca PLC, Cambridge, UK.
3
Cardiovascular, Renal and Metabolism Biopharmaceuticals R&D, AstraZeneca PLC, Gothenburg, UK.
4
Research and Early Development, Respiratory and Immunology, AstraZeneca PLC, Cambridge, UK.
5
Oncology, AstraZeneca PLC, Cambridge, UK.
6
Research and Development, AstraZeneca PLC, Gaithersburg, MD, US.
7
Digital Health Oncology Research and Development, AstraZeneca PLC, San Francisco, CA, USA.
8
Emmette Hutchison LLC, Naples, FL, USA.
9
Biophamaceuticals Research and Development, AstraZeneca PLC, Cambridge, UK.
10
Oncology Research and Development, AstraZeneca PLC, Gaithersburg, MD, USA.
PMID:
37587220
DOI:
10.1038/s41591-023-02489-z
No abstract available